High-dose radiation treatment effective at fighting some cancers in children

December 12, 2001

COLUMBUS, Ohio - Directing high-level doses of radiation at malignant tumors during surgery shows promise in treating certain childhood cancers.

Eleven of 13 children in an Ohio State University study remained cancer-free an average of four years after treatment with a technique called intraoperative high-dose-rate brachytherapy (IO-HDRBT). Ten of the surviving children were treated during advanced stages of their diseases.

"Most of the children in the study likely would have died if we hadn't used this treatment," said Subir Nag, chief of brachytherapy and professor of clinical radiology at the Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute at Ohio State.

IO-HDRBT delivers a one-time dose of radiation directly to tumors in hard-to-reach areas of the body, such as the base of the skull and the sides of the pelvis and the abdomen. It's especially useful in treating children, whose small size can sometimes prevent surgeons from using other methods to completely remove tumors.

The research appears in a recent issue of the International Journal of Radiation Oncology, Biology, Physics.

Nag and his colleagues treated and followed 13 children, ages 2 to 14, during a seven-year period. Each child had cancer of a soft tissue, such as rhabdomyosarcoma (a cancer of the muscle) and chondrosarcoma (a cancer of the cartilage). All children were treated with IO-HDRBT in conjunction with radical surgery, chemotherapy and external beam radiation therapy (a treatment that targets the tumor through layers of healthy, normal tissue).

"A single dose of high-dose radiation isn't enough to eradicate the disease," Nag said. But applying the one-time high dose of radiation right at the site of the tumor reduces the dose of radiation to healthy tissues. Conventional external beam radiation therapy, while necessary for treating most pediatric tumors, can cause unwanted side effects in tissues near the tumor - often resulting in growth deformities.

"It hampers bone formation, for one thing," Nag said. "We try to avoid or minimize using external radiation in children as much as possible. But avoiding it sometimes means that the tumor returns. "Brachytherapy lets us apply radiation directly to the tumor site, in turn giving them more control over the area. As a result, lower levels of external radiation and other cancer-fighting treatments need to be used."

After removing the bulk of the tumor through surgery, IO-HDRBT lets physicians apply radiation via a catheter to the tumor site. The radiation treatment itself lasts 15 to 20 minutes. The catheter is then removed and the wound is stitched. Healthy tissues surrounding the tumor are temporarily moved an inch or two away from the tumor during the radiation treatment in order to reduce the exposure of these tissues to the radiation.

"We can move bone, nerves and even bowel tissue out of the way," Nag said.

The highest recommended dose of external beam radiation therapy for treating soft tissue cancers is 41.4 Gy - radiation is measured in units called the Gray equivalent, or Gy.

"If we had used these guidelines, most of the threshold doses for normal tissue exposure in children would have been exceeded if the entire treatment had been delivered using external beam radiation therapy," Nag said. "While external beam radiation is needed to fight tumors, it can cause growth retardation or adversely affect organ function in children."

He and his colleagues were able to limit external beam radiation therapy to less than 30 Gy in most cases by using IO-HDRBT.

IO-HDRBT is best used on the hard-to-reach areas inside the body - narrow cavities and corners and curves that are difficult to treat with other treatment methods.

A technique comparable to IO-HDRBT, simply called high-dose-rate brachytherapy, involves leaving the catheter in place on the tumor for up to a week. In these cases, the tumor is usually very small, as is the radiation risk to surrounding tissues. Typically there is no need for additional treatments.

"Some patients don't fit the criteria for high-dose radiation brachytherapy," Nag said. "Leaving the catheter in for an extended time period is very difficult in young children. The intraoperative technique allows us to be more precise in directing exactly where the radiation goes without having to leave catheters in place."
-end-
Nag conducted the study with Douglas Tippin of the James Cancer Hospital at Ohio State and Frederick Ruymann of Children's Hospital in Columbus and the Comprehensive Cancer Center at Ohio State.

Contact: Subir Nag, 614-293-3246; Nag.1@osu.edu
Written by Holly Wagner, 614-292-8310; Wagner.235@osu.edu

Ohio State University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.